Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts.

Duquesnoy Rj, Robert Hardesty(University of Pittsburgh), Christina L. Kaufman(University of Louisville), Alfredo Trento(Cedars-Sinai Medical Center), John J. Fung(University of Chicago), Robert L. Kormos(Abbott Northwestern Hospital), Zerbe Tr, Bartley P. Griffith(University of Maryland, Baltimore), A. Zeevi
PubMed
February 1, 1987
Cited by 15

Related Papers

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
|Hepatology|1997|1.3k
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
|The Lancet|1984|1.3k
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2020|832
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655